Healthcare provider profile · identity verified

Eric W. Sorenson, M.D.

Family Practice · MENOMONIE, WI · NPI 1952339574

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	513	138
Levothyroxine Sodium	Levothyroxine Sodium	321	73
Losartan Potassium	Losartan Potassium	253	69
Amlodipine Besylate	Amlodipine Besylate	240	68
Lisinopril	Lisinopril	238	64
Omeprazole	Omeprazole	215	54
Metoprolol Succinate	Metoprolol Succinate	199	55
Metformin Hcl Er	Metformin Hcl	196	45
Furosemide	Furosemide	186	52
Metoprolol Tartrate	Metoprolol Tartrate	181	49
Eliquis	Apixaban	176	25
Sertraline Hcl	Sertraline Hcl	168	38
Gabapentin	Gabapentin	154	41
Simvastatin	Simvastatin	148	42
Trazodone Hcl	Trazodone Hcl	140	33
Metformin Hcl	Metformin Hcl	124	33
Pantoprazole Sodium	Pantoprazole Sodium	124	33
Rosuvastatin Calcium	Rosuvastatin Calcium	114	27
Warfarin Sodium	Warfarin Sodium	114	20
Hydrochlorothiazide	Hydrochlorothiazide	112	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	108	31
Tamsulosin Hcl	Tamsulosin Hcl	102	27
Escitalopram Oxalate	Escitalopram Oxalate	88	17
Duloxetine Hcl	Duloxetine Hcl	85	17
Allopurinol	Allopurinol	81	22
Zolpidem Tartrate	Zolpidem Tartrate	75	suppressed
Spironolactone	Spironolactone	72	19
Trulicity	Dulaglutide	72	13
Fluoxetine Hcl	Fluoxetine Hcl	71	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	15
Paroxetine Hcl	Paroxetine Hcl	64	12
Potassium Chloride	Potassium Chloride	63	17
Fluticasone Propionate	Fluticasone Propionate	62	25
Glipizide Er	Glipizide	62	17
Albuterol Sulfate Hfa	Albuterol Sulfate	61	35
Meloxicam	Meloxicam	57	24
Quetiapine Fumarate	Quetiapine Fumarate	57	suppressed
Famotidine	Famotidine	56	15
Prednisone	Prednisone	54	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	17
Clopidogrel	Clopidogrel Bisulfate	50	13
Montelukast Sodium	Montelukast Sodium	50	12
Aripiprazole	Aripiprazole	48	suppressed
Bupropion Xl	Bupropion Hcl	48	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	13
Baclofen	Baclofen	46	suppressed
Pravastatin Sodium	Pravastatin Sodium	46	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	suppressed
Alprazolam	Alprazolam	41	suppressed
Chlorthalidone	Chlorthalidone	40	suppressed
Glimepiride	Glimepiride	39	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	38	suppressed
Pregabalin	Pregabalin	36	suppressed
Torsemide	Torsemide	36	suppressed
Glipizide	Glipizide	35	suppressed
Ozempic	Semaglutide	35	11
Verapamil Er	Verapamil Hcl	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Atenolol	Atenolol	34	12
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Ventolin Hfa	Albuterol Sulfate	34	14
Citalopram Hbr	Citalopram Hydrobromide	33	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Methenamine Hippurate	Methenamine Hippurate	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Finasteride	Finasteride	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	12
Diclofenac Sodium	Diclofenac Sodium	25	13
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Valsartan	Valsartan	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Lovastatin	Lovastatin	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Latanoprost	Latanoprost	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	18	suppressed
Colestipol Hcl	Colestipol Hcl	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Indapamide	Indapamide	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Nyamyc	Nystatin	15	suppressed
Balsalazide Disodium	Balsalazide Disodium	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Lactulose	Lactulose	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Nystatin	Nystatin	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Rytary	Carbidopa/Levodopa	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Belsomra	Suvorexant	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Primidone	Primidone	11	suppressed
Risperidone	Risperidone	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error